Global Human Immunodeficiency Virus Therapeutics market size is expected to reach $19.4 billion by 2030 at 5.4%, increase in unprotected sexual practices fueling the market due to limited access to contraception and lack of comprehensive sex education
Read MoreGlobal Human Immunodeficiency Virus (HIV) Diagnosis market size is expected to reach $7.4 billion by 2030 at 9.3%, segmented as by consumables, test kits (rapid hiv test kits, elisa test kits), reagents and chemicals
Read MoreGlobal Human Growth Hormone market size is expected to reach $7.87 billion by 2030 at 8.5%, segmented as by liquid, pre-filled liquid syringes, vials of liquid growth hormone
Read MoreThe human epidermal growth factor market will grow from $3.66 in 2025 to $2.39B in 2026 at 8.9% CAGR, driven by demand for wound care and skincare solutions.
Read MoreGlobal Human Embryonic Stem Cells market size is expected to reach $2.12 billion by 2030 at 8.9%, segmented as by totipotent stem cells, embryonic totipotent stem cells, induced totipotent stem cells
Read MoreGlobal Human Chorionic Gonadotropin market size is expected to reach $1.52 billion by 2030 at 8.2%, segmented as by natural source extraction, extraction from pregnant women’s urine, extraction from animal sources
Read MoreThe hospitals and outpatient care centers market is projected to reach $5856.89 billion by 2030, growing at 4.3% CAGR, driven by outpatient care adoption, specialty clinics, and accessible healthcare services.
Read MoreGlobal Polyetheretherketone (PEEK) Implants Industry Trends and Market Growth Forecast for 2026–2030
Polyetheretherketone implants market to reach $2.29 bn by 2030 at 8.1% CAGR, driven by rising orthopedic surgeries & advancements in patient-specific implants.
Read MorePolyether Ether Ketone interbody devices market to reach $2.74 bn by 2030 at 7.3% CAGR, driven by rise in spinal disorders & advanced surgical techniques.
Read MoreGlobal Point-Of-Care Molecular Diagnostics market size is expected to reach $7.91 billion by 2030 at 14.7%, rising respiratory infections drive demand for point-of-care molecular diagnostics
Read More